Description

The Tumor Markers Test Kit YRA299 // YRA316 is a cutting-edge diagnostic tool designed for use with chemiluminescence immunoassay analyzers. This test kit can detect a broad range of 18 different tumor markers, making it an invaluable resource for early cancer detection. Compatible with the Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, it accurately measures the elevation of tumor markers in blood, aiding in the identification of various malignant tumors.

Each kit is developed to deliver precise and reliable results thanks to its CLIA (Chemiluminescence Immunoassay) mode and alkaline phosphatase platform, ensuring optimal performance. Packaged in configurations of 50T/BOX, 100T/BOX, and 24T/BOX, the kit meets different testing demands and comes with necessary certifications, including CE, ISO13485, and FSC, highlighting its adherence to international quality standards.

For healthcare facilities seeking state-of-the-art diagnostic tools, this test kit offers a robust solution for monitoring and diagnosing cancer, ultimately enhancing patient care outcomes. For pricing details and to initiate a quote, visit the Kalstein Plus platform today to access competitive market rates.

Market Price

The market price for the Tumor Markers Test Kit YRA299 // YRA316 can vary based on the supplier and volume. Typically, these kits are available in the range of $500 to $1500 per box, depending on the number of tests included and specific configurations. Manufacturers often offer discounts for bulk purchases or long-term supply contracts, allowing laboratories to manage costs effectively.

Frequently Asked Questions

What is the shelf life of the test kit?

The Tumor Markers Test Kit YRA299 // YRA316 should be stored at 2-8°C and generally has a shelf life of 12 months from the date of manufacture. Please ensure correct storage conditions to maintain product efficacy.

How can this kit aid in cancer diagnostics?

By measuring the elevation of various tumor markers, the kit helps in the early detection and precise identification of malignancies, assisting healthcare providers in developing timely treatment plans.

Advantages and Disadvantages

Advantages:

• Highly sensitive and specific results for early cancer detection.
• Wide range of tumor markers covered using a single kit.
• Certified quality with CE, ISO13485, and FSC approvals.

Disadvantages:

• Requires compatible chemiluminescence immunoassay analyzers.
• Initial investment might be higher compared to simpler diagnostic tests.

Field Usage

In clinical settings, the Tumor Markers Test Kit YRA299 // YRA316 is employed by laboratory technicians using compatible chemiluminescence analyzers. Blood samples are collected and processed to assess the levels of specific tumor markers, with results informing diagnostic and treatment pathways. By integrating these tests into routine check-ups, medical professionals can effectively monitor patient health and anticipate potential oncology issues.

Recommendations

To ensure the maximum efficacy of the Tumor Markers Test Kit, it is recommended to conduct regular calibrations using the two or six-point calibration system. Proper storage conditions between 2-8°C should be maintained, and technicians should follow the manufacturer’s guidelines on handling and disposal post-testing. Investing in training for laboratory staff can further enhance the accuracy and reliability of test results.

Features

• Compatible with YR06389 and YR06390 analyzers.
• Enables early detection of cancer through blood tests.
• Supports 18 types of tumor markers.
• Uses chemiluminescence immunoassay method (CLIA) for high precision.
• Various packaging options available to meet different laboratory needs.
• Fully certified for reliability and quality.

Technical Specifications